Immunotoxicological investigations in the mouse: general approach and methods.
The adverse effects of chemicals on the lymphoreticular system have generated considerable toxicological interest. In this series of papers, the effects of selected environmentally relevant compounds are reported. This first paper describes the methods and general approach used in judging a chemical's potential risk to the immune system. Risk evaluation was approached utilizing acute, 14- and 90-day studies. Both sexes of the CD-1 random-bred mouse were employed. The immune system was evaluated against a background of more standard toxicological parameters, which included fluid consumption, body and organ weights, hematology, serum and liver chemistries, hepatic microsomal enzyme activities and blood coagulation. Bone marrow status was evaluated by assessing DNA synthesis. Humoral immunity was evaluated by determining the number of IgM spleen antibody-forming cells (AFC) to sheep erythrocytes (sRBC), the serum antibody level to sRBC, and spleen lymphocyte response to the B cell mitogen, lipopolysaccharide (LPS). The status of cell-mediated immunity was assessed by quantitating the delayed type hypersensitivity (DTH) response to sRBC, proliferation of the popliteal lymph node, and the spleen cell response to the T lymphocyte mitogen, Concanavalin A (Con A). Macrophage function was evaluated by measurement of the vascular clearance rate and distribution of radiolabeled sRBC in the liver, spleen, lungs, and thymus, and recruitability, adherence, chemotaxis, and phagocytic activity of peritoneal exudate cells (PEC). Historical control data from six 14- and 90-day studies conducted over a one year period are given. The data resulting from these types of studies can provide a basis for the initial evaluation of a chemical's adverse effect on the immune system.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001774:Blood Chemical Analysis; D001777:Blood Coagulation / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000378:metabolism; D005260:Female; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000378:metabolism; D012157:Mononuclear Phagocyte System / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D004364:Pharmaceutical Preparations / Q000378:metabolism
D004364:Pharmaceutical Preparations; D006899:Mixed Function Oxygenases